# A Study to Evaluate Readiness to Self-inject on Adherence and Compliance to Copaxone® Therapy

> **NCT00238654** · — · COMPLETED · sponsor: **Teva Neuroscience, Inc.** · enrollment: 257 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00238654
- **Lead sponsor:** Teva Neuroscience, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2003-05
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 257 (ACTUAL)
- **Last updated:** 2011-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00238654

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00238654, "A Study to Evaluate Readiness to Self-inject on Adherence and Compliance to Copaxone® Therapy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00238654. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*